Doctor profile · Federal record

Dr. Shadi Haddadin, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Jefferson City, MO

  • NPI 1073611919
  • Accepts Medicare
  • 25 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1241 W Stadium Blvd
Jefferson City, MO 651096023
(573) 556-7718
Mailing address
Po Box 104240
Jefferson City, MO 651104240

Credentials & registration

NPPES · NUCC
NPI registered
September 2006 — 20 yrs on file
Profile last updated
December 10, 2014
Year of graduation
2001 — 25 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Missouri #2008003781
Medicaid
MO #1073611919

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1073611919. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
84,881
Distinct HCPCS
10
Medicare allowed
$2,808,479
HCPCS Description Services Patients Avg allowed
J9271 Injection, pembrolizumab, 1 mg 25,600 15 $54
J0897 Injection, denosumab, 1 mg 12,300 28 $23
J0185 Injection, aprepitant, 1 mg 8,580 16 $2
J1437 Injection, ferric derisomaltose, 10 mg 5,800 49 $21
J1556 Injection, immune globulin (bivigam), 500 mg 5,290 12 $71
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 3,900 11 $29
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,478 81 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 2,346 616 $8
J2469 Injection, palonosetron hcl, 25 mcg 2,076 33 $1
36415 Insertion of needle into vein for collection of blood sample 1,564 582 $8

In context: peer comparison

Among 5 peers in Jefferson City Hematology & Oncology Physician, average services per provider: 935. This provider delivers 91× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$8,742
Transactions
68
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 8 $5,285.47
BeiGene USA, INC. 1 $2,250.00
Daiichi Sankyo INC. 8 $263.81
E.R. Squibb & Sons, L.L.C. 13 $166.72
Novartis Pharmaceuticals Corporation 6 $137.78
Pfizer INC. 11 $126.44
Celgene Corporation 6 $97.86
Abbvie INC. 4 $93.66
Regeneron Healthcare Solutions, INC. 4 $77.75
Emd Serono, INC. 2 $38.80
Takeda Pharmaceuticals U.S.A., INC. 1 $30.89
Alnylam Pharmaceuticals INC. 1 $25.30
Adc Therapeutics America, INC. 1 $24.64
Celltrion USA INC. 1 $24.00
SpringWorks Therapeutics, INC. 1 $22.17

By nature of payment

Consulting Fee
$7,428
Food and Beverage
$1,183
Education
$132

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,601
Patients
365
Total drug cost
$439,920
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 230 38 $5,431
Anastrozole Generic 180 42 $4,972
Eliquis (Apixaban) Brand 132 30 $88,721
Hydroxyurea Generic 130 22 $3,734
Gabapentin Generic 114 34 $1,826
Letrozole Generic 113 25 $3,218
Xarelto (Rivaroxaban) Brand 95 22 $78,406
Tamoxifen Citrate Generic 93 25 $4,133
Dexamethasone Generic 92 37 $2,089
Levothyroxine Sodium Generic 85 21 $954

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Shadi Haddadin's medical specialty?
Dr. Shadi Haddadin practices Hematology & Oncology Physician in Jefferson City, MO.
Where does Dr. Shadi Haddadin practice?
Dr. Shadi Haddadin practices at 1241 W Stadium Blvd, Jefferson City, MO 651096023. Office phone: 5735567718.
What is Dr. Shadi Haddadin's NPI?
Dr. Shadi Haddadin's National Provider Identifier (NPI) is 1073611919, issued by NPPES.
Does Dr. Shadi Haddadin accept Medicare assignment?
Yes. Dr. Shadi Haddadin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shadi Haddadin commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.